Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Lai, Quirino; Halazun, Karim J.; Iesari, Samuele et al.
Proposal for a Worldwide Usable Score for the Prediction of Recurrence and Intention-to-Treat Survival after Liver Transplantation in Patients with Hepatocellular Cancer: A West-East Analysis on 1,903 PatientsTRANSPLANTATION. Bd. 102. 2018 S. S252-S252
Singer, Susanne; Roick, Julia; Danker, Helge et al.
Psychiatric co-morbidity, distress, and use of psycho-social services in adult glioma patients-a prospective studyACTA NEUROCHIRURGICA. Bd. 160. H. 6. 2018 S. 1187-1194
Sischka, Kerstin; Filter, Simone; Singer, Susanne
Psychoanalytical competence in training and further education Results of a survey among DGPT candidates and considerations on the reform of the German Psychotherapist ActFORUM DER PSYCHOANALYSE. Bd. 34. H. 3. 2018 S. 249-265
Eichler, Martin; Hechtner, Marlene; Wehler, Beatrice et al.
Psychological distress in lung cancer survivors at least 1year after diagnosisResults of a German multicenter cross-sectional studyPSYCHO-ONCOLOGY. Bd. 27. H. 8. 2018 S. 2002-2008
Buchler, Britta; Worns, Marcus-Alexander; Singer, Susanne
Psychological well-being in liver cancer patientsONKOLOGE. Bd. 24. H. 9. 2018 S. 725-730
Hechtner, Marlene; Eichler, Martin; Buhl, Roland et al.
Quality of life of survivors of non-small cell lung cancer. Overview of associated factors and requirements for aftercareONKOLOGE. Bd. 24. H. 12. 2018 S. 1015-1022
Lorenz, Eva; Scholz-Kreisel, Peter; Baaken, Dan et al.
Radiotherapy for childhood cancer and subsequent thyroid cancer risk: a systematic reviewEUROPEAN JOURNAL OF EPIDEMIOLOGY. Bd. 33. H. 12. 2018 S. 1139-1162
Zhu, A. X.; Finn, R. S.; Galle, P. R. et al.
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Patient reported outcome results across two phase III studies (REACH-2 and REACH)ANNALS OF ONCOLOGY. Bd. 29. 2018 S. 208-208
Llovet, Josep M.; Kudo, Masatoshi; Finn, Richard et al.
Ramucirumab As Second-Line Treatment in Patients with Hepatocellular Carcinoma (HCC) and Elevated Alpha-Fetoprotein (AFP) Following Sorafenib: Pooled Results from Two Global Phase 3 Studies (REACH-2 and REACH)HEPATOLOGY. Bd. 68. 2018 S. 166A-166A
Zhu, Andrew X.; Kang, Yoon-Koo; Yen, Chia-Jui et al.
REACH-2: A randomized, double-blind, placebo-controlled phase 3 study of ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline alpha-fetoprotein (AFP) following first-line sorafenib.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018